Assembly Biosciences (ASMB) Consolidated Net Income (2016 - 2025)
Historic Consolidated Net Income for Assembly Biosciences (ASMB) over the last 9 years, with Q3 2025 value amounting to -$9.2 million.
- Assembly Biosciences' Consolidated Net Income rose 433.79% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.5 million, marking a year-over-year increase of 553.13%. This contributed to the annual value of -$40.2 million for FY2024, which is 3438.13% up from last year.
- Latest data reveals that Assembly Biosciences reported Consolidated Net Income of -$9.2 million as of Q3 2025, which was up 433.79% from -$10.2 million recorded in Q2 2025.
- In the past 5 years, Assembly Biosciences' Consolidated Net Income ranged from a high of -$8.8 million in Q1 2025 and a low of -$62.8 million during Q4 2021
- In the last 4 years, Assembly Biosciences' Consolidated Net Income had a median value of -$11.2 million in 2024 and averaged -$17.5 million.
- In the last 5 years, Assembly Biosciences' Consolidated Net Income crashed by 46145.12% in 2021 and then skyrocketed by 5210.03% in 2024.
- Quarter analysis of 4 years shows Assembly Biosciences' Consolidated Net Income stood at -$62.8 million in 2021, then skyrocketed by 82.54% to -$11.0 million in 2023, then grew by 5.72% to -$10.3 million in 2024, then increased by 11.02% to -$9.2 million in 2025.
- Its Consolidated Net Income stands at -$9.2 million for Q3 2025, versus -$10.2 million for Q2 2025 and -$8.8 million for Q1 2025.